General MedicationsSOLUTIONStandard
TEVIMBRA
TISLELIZUMAB-JSGR
Standard Dose
100MG/10ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TEVIMBRA is listed in Drugs@FDA under application 761232 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TISLELIZUMAB-JSGR Form and strength INJECTION;SOLUTION - 100MG/10ML Sponsor BEIGENE Submission history Latest submission status date: 2025-12-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview TEVIMBRA is listed in Drugs@FDA under application 761232 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient TISLELIZUMAB-JSGR Form and strength INJECTION;SOLUTION - 100MG/10ML Sponsor BEIGENE Submission history Latest submission status date: 2025-12-09 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.